Y Intercept Hong Kong Ltd Purchases Shares of 58,284 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Y Intercept Hong Kong Ltd bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 58,284 shares of the company's stock, valued at approximately $5,470,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of GEHC. LGT Financial Advisors LLC lifted its position in shares of GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 251 shares during the last quarter. Fred Alger Management LLC bought a new stake in GE HealthCare Technologies during the 2nd quarter valued at about $26,000. Capital Performance Advisors LLP purchased a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Ashton Thomas Securities LLC bought a new position in GE HealthCare Technologies in the 3rd quarter worth about $26,000. Finally, Elkhorn Partners Limited Partnership purchased a new position in shares of GE HealthCare Technologies during the second quarter worth approximately $31,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Up 0.8 %

Shares of NASDAQ GEHC traded up $0.66 during midday trading on Monday, reaching $81.90. 2,372,598 shares of the stock were exchanged, compared to its average volume of 3,052,767. The stock has a market capitalization of $37.42 billion, a P/E ratio of 22.50, a PEG ratio of 2.91 and a beta of 1.08. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The company has a 50 day simple moving average of $86.56 and a 200 day simple moving average of $83.70. GE HealthCare Technologies Inc. has a twelve month low of $69.09 and a twelve month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating analysts' consensus estimates of $1.06 by $0.08. The company had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company's revenue for the quarter was up .9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.99 earnings per share. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a $0.035 dividend. This is a positive change from GE HealthCare Technologies's previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. GE HealthCare Technologies's payout ratio is presently 3.30%.

Insiders Place Their Bets

In related news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.27% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

GEHC has been the topic of several research analyst reports. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. Stifel Nicolaus boosted their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a report on Monday, September 30th. Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a research note on Tuesday, October 1st. BTIG Research upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 target price for the company in a report on Wednesday, September 18th. Finally, JPMorgan Chase & Co. assumed coverage on GE HealthCare Technologies in a report on Monday, September 9th. They issued a "neutral" rating and a $90.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $95.46.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.